HEADER BLOOD CLOTTING 29-SEP-05 2B5T TITLE 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN TITLE 2 ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A TITLE 3 THROMBIN MOLECULES CAVEAT 2B5T NAG F 1 HAS WRONG CHIRALITY AT ATOM C1 GU6 G 15 HAS WRONG CAVEAT 2 2B5T CHIRALITY AT ATOM C5 NAG H 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: THROMBIN LIGHT CHAIN; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THROMBIN; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: THROMBIN HEAVY CHAIN, SERINE PROTEASE; COMPND 11 SYNONYM: COAGULATION FACTOR II; COMPND 12 EC: 3.4.21.5; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: ANTITHROMBIN-III; COMPND 17 CHAIN: I; COMPND 18 SYNONYM: ATIII; COMPND 19 ENGINEERED: YES; COMPND 20 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F2; SOURCE 6 EXPRESSION_SYSTEM: MESOCRICETUS AURATUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: GOLDEN HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10036; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: BHK CELL LINE; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: F2; SOURCE 15 EXPRESSION_SYSTEM: MESOCRICETUS AURATUS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: GOLDEN HAMSTER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10036; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: BHK CELL LINE; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 GENE: SERPINC1, AT3; SOURCE 24 EXPRESSION_SYSTEM: MESOCRICETUS AURATUS; SOURCE 25 EXPRESSION_SYSTEM_COMMON: GOLDEN HAMSTER; SOURCE 26 EXPRESSION_SYSTEM_TAXID: 10036; SOURCE 27 EXPRESSION_SYSTEM_CELL_LINE: BHK CELL LINE KEYWDS BLOOD COAGULATION, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR D.J.JOHNSON,W.LI,S.A.LUIS,R.W.CARRELL,J.A.HUNTINGTON REVDAT 8 13-NOV-24 2B5T 1 REMARK REVDAT 7 23-AUG-23 2B5T 1 REMARK REVDAT 6 20-OCT-21 2B5T 1 SEQADV HETSYN REVDAT 5 29-JUL-20 2B5T 1 CAVEAT COMPND REMARK HET REVDAT 5 2 1 HETNAM FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 13-JUL-11 2B5T 1 VERSN REVDAT 3 16-MAR-10 2B5T 1 JRNL REVDAT 2 24-FEB-09 2B5T 1 VERSN REVDAT 1 19-SEP-06 2B5T 0 JRNL AUTH D.J.JOHNSON,J.LANGDOWN,W.LI,S.A.LUIS,T.P.BAGLIN, JRNL AUTH 2 J.A.HUNTINGTON JRNL TITL CRYSTAL STRUCTURE OF MONOMERIC NATIVE ANTITHROMBIN REVEALS A JRNL TITL 2 NOVEL REACTIVE CENTER LOOP CONFORMATION. JRNL REF J.BIOL.CHEM. V. 281 35478 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16973611 JRNL DOI 10.1074/JBC.M607204200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1108259.950 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 71924 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2937 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 10600 REMARK 3 BIN R VALUE (WORKING SET) : 0.3230 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 450 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8044 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 551 REMARK 3 SOLVENT ATOMS : 389 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.76000 REMARK 3 B22 (A**2) : -7.80000 REMARK 3 B33 (A**2) : 7.04000 REMARK 3 B12 (A**2) : 6.67000 REMARK 3 B13 (A**2) : -10.07000 REMARK 3 B23 (A**2) : -1.18000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.510 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.460 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.650 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.130 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 42.73 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NEW_LABELS2.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : GOL.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NEW_LABELS2.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : GOL.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2B5T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000034710. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71994 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 35.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : 0.07500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : 0.44000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1PPB AND 1NQ9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, GLYCEROL, AMMONIUM SULFATE, REMARK 280 (CRYSTALLIZED WITH NACL AND TRIS, BUT NOT IN CRYOPROTECTANT), PH REMARK 280 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, I, E, F, G, H, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 21880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 -59.28000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, I, F, G, H, J REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 1U REMARK 465 ALA A 1T REMARK 465 TRP B 147A REMARK 465 THR B 147B REMARK 465 ALA B 147C REMARK 465 ASN B 147D REMARK 465 VAL B 147E REMARK 465 GLY B 147F REMARK 465 LYS B 147G REMARK 465 THR C 1U REMARK 465 ALA C 1T REMARK 465 THR C 1S REMARK 465 TRP D 147A REMARK 465 THR D 147B REMARK 465 ALA D 147C REMARK 465 ASN D 147D REMARK 465 VAL D 147E REMARK 465 GLY D 147F REMARK 465 LYS D 147G REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 VAL I 5 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 110 CD CE NZ REMARK 470 GLU B 127 CD OE1 OE2 REMARK 470 ARG C 14D CG CD NE CZ NH1 NH2 REMARK 470 ARG D 75 CD NE CZ NH1 NH2 REMARK 470 LYS D 81 CD CE NZ REMARK 470 LYS D 109 CG CD CE NZ REMARK 470 LYS D 110 CE NZ REMARK 470 LYS D 145 CE NZ REMARK 470 ASP I 14 CG OD1 OD2 REMARK 470 MET I 17 CG SD CE REMARK 470 LYS I 39 CG CD CE NZ REMARK 470 GLU I 42 CG CD OE1 OE2 REMARK 470 ARG I 132 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 133 CG CD CE NZ REMARK 470 ASN I 135 CG OD1 ND2 REMARK 470 LYS I 136 CG CD CE NZ REMARK 470 LYS I 139 CD CE NZ REMARK 470 LEU I 164 CG CD1 CD2 REMARK 470 GLU I 180 CD OE1 OE2 REMARK 470 LYS I 188 CD CE NZ REMARK 470 ARG I 197 CD NE CZ NH1 NH2 REMARK 470 GLU I 245 CG CD OE1 OE2 REMARK 470 LYS I 257 CD CE NZ REMARK 470 LYS I 275 CD CE NZ REMARK 470 GLU I 289 CG CD OE1 OE2 REMARK 470 LYS I 294 CD CE NZ REMARK 470 LYS I 297 CG CD CE NZ REMARK 470 GLU I 306 CG CD OE1 OE2 REMARK 470 GLU I 347 CD OE1 OE2 REMARK 470 ARG I 359 CG CD NE CZ NH1 NH2 REMARK 470 LYS I 403 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -78.73 -136.12 REMARK 500 TYR B 60A 85.42 -159.90 REMARK 500 HIS B 71 -58.98 -130.42 REMARK 500 ASN B 78 -4.11 66.81 REMARK 500 GLU B 97A -81.59 -97.97 REMARK 500 ASP B 186A 4.47 -66.55 REMARK 500 PRO C 1J -8.31 -54.28 REMARK 500 PHE C 7 -77.04 -136.15 REMARK 500 PRO D 28 -6.84 -59.50 REMARK 500 TYR D 60A 78.22 -154.12 REMARK 500 ASN D 60G 87.52 -152.32 REMARK 500 HIS D 71 -59.21 -130.37 REMARK 500 ASN D 78 16.04 58.62 REMARK 500 ILE D 79 -63.05 -123.18 REMARK 500 ASN D 98 -169.50 -174.56 REMARK 500 SER D 115 -163.06 -164.33 REMARK 500 MET I 17 -90.16 -119.89 REMARK 500 ASN I 18 116.79 62.07 REMARK 500 ASP I 72 -4.24 -52.95 REMARK 500 ASN I 96 -137.64 52.03 REMARK 500 ALA I 134 30.99 28.51 REMARK 500 ASN I 135 35.16 -70.00 REMARK 500 LYS I 136 -0.52 31.14 REMARK 500 SER I 138 84.74 -161.07 REMARK 500 GLU I 195 101.13 18.39 REMARK 500 ASP I 200 51.91 -147.00 REMARK 500 ILE I 219 142.89 176.87 REMARK 500 LYS I 241 -178.25 -54.70 REMARK 500 GLU I 245 -174.93 -65.48 REMARK 500 SER I 250 91.23 -63.91 REMARK 500 ARG I 261 126.14 -170.85 REMARK 500 VAL I 263 -159.11 -106.29 REMARK 500 ASP I 277 -0.88 75.57 REMARK 500 GLU I 289 -79.27 -59.98 REMARK 500 GLU I 357 -152.88 87.04 REMARK 500 ARG I 359 -83.53 -55.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN H 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NQ9 RELATED DB: PDB REMARK 900 PENTASACCHARIDE-BOUND ANTITHROMBIN IN ITS INTERMEDIATE STATE. REMARK 900 RELATED ID: 1TB6 RELATED DB: PDB REMARK 900 MONOMERIC ANTITHROMBIN VARIANT V317C/T401C IN MICHAELIS COMPLEX REMARK 900 WITH SR123781 AND S195A THROMBIN. REMARK 900 RELATED ID: 1T1F RELATED DB: PDB REMARK 900 MONOMERIC ANTITHROMBIN VARIANT V317C/T401C DBREF 2B5T A 1U 15 UNP P00734 THRB_HUMAN 315 363 DBREF 2B5T C 1U 15 UNP P00734 THRB_HUMAN 315 363 DBREF 2B5T B 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 2B5T D 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 2B5T I 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQADV 2B5T ALA B 195 UNP P00734 SER 568 ENGINEERED MUTATION SEQADV 2B5T ALA D 195 UNP P00734 SER 568 ENGINEERED MUTATION SEQADV 2B5T ALA I 137 UNP P01008 SER 169 ENGINEERED MUTATION SEQADV 2B5T CYS I 317 UNP P01008 VAL 349 ENGINEERED MUTATION SEQADV 2B5T CYS I 401 UNP P01008 THR 433 ENGINEERED MUTATION SEQRES 1 A 49 THR ALA THR SER GLU TYR GLN THR PHE PHE ASN PRO ARG SEQRES 2 A 49 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 3 A 49 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 4 A 49 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP ALA GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 C 49 THR ALA THR SER GLU TYR GLN THR PHE PHE ASN PRO ARG SEQRES 2 C 49 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 3 C 49 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 4 C 49 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 D 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 D 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 D 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 D 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 D 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 D 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 D 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 D 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 D 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 D 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 D 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 D 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 D 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 D 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 D 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 D 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP ALA GLY GLY PRO SEQRES 17 D 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 D 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 D 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 D 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS ALA SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU CYS VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL CYS PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS MODRES 2B5T ASN B 60G ASN GLYCOSYLATION SITE MODRES 2B5T ASN D 60G ASN GLYCOSYLATION SITE MODRES 2B5T ASN I 96 ASN GLYCOSYLATION SITE MODRES 2B5T ASN I 155 ASN GLYCOSYLATION SITE MODRES 2B5T ASN I 192 ASN GLYCOSYLATION SITE HET NAG E 1 14 HET FUC E 2 10 HET NAG F 1 14 HET FUC F 2 10 HET GU3 G 1 22 HET GU2 G 2 14 HET GU6 G 3 23 HET GU1 G 4 14 HET GU5 G 5 17 HET GU8 G 6 14 HET GU9 G 7 14 HET GU8 G 8 14 HET GU9 G 9 14 HET GU8 G 10 14 HET GU9 G 11 14 HET GU8 G 12 14 HET GU5 G 13 17 HET GU0 G 14 23 HET GU6 G 15 23 HET GU4 G 16 27 HET NAG H 1 14 HET NAG H 2 14 HET BMA H 3 11 HET MAN H 4 11 HET MAN H 5 10 HET MAN H 6 11 HET FUC H 7 10 HET NAG J 1 14 HET NAG J 2 14 HET GOL A1102 6 HET GOL A1108 6 HET SO4 B2001 5 HET SO4 B2002 5 HET SO4 B2003 5 HET SO4 B2006 5 HET GOL B1101 6 HET GOL B1103 6 HET GOL B1104 6 HET GOL B1105 6 HET GOL B1109 6 HET SO4 D2004 5 HET GOL D1106 6 HET GOL D1107 6 HET GOL D1110 6 HET GOL D1111 6 HET NAG I 801 14 HET SO4 I2005 5 HET GOL I1112 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM GU3 METHYL 3-O-METHYL-2,6-DI-O-SULFO-ALPHA-D- HETNAM 2 GU3 GLUCOPYRANOSIDE HETNAM GU2 2,3-DI-O-METHYL-ALPHA-L-IDOPYRANURONIC ACID HETNAM GU6 2,3,6-TRI-O-SULFO-ALPHA-D-GLUCOPYRANOSE HETNAM GU1 2,3-DI-O-METHYL-BETA-D-GLUCOPYRANURONIC ACID HETNAM GU5 2,3-DI-O-METHYL-6-O-SULFONATO-ALPHA-D-GLUCOPYRANOSE HETNAM GU8 2,3,6-TRI-O-METHYL-BETA-D-GLUCOPYRANOSE HETNAM GU9 2,3,6-TRI-O-METHYL-ALPHA-D-GLUCOPYRANOSE HETNAM GU0 2,3,6-TRI-O-SULFONATO-BETA-D-GLUCOPYRANOSE HETNAM GU4 2,3,4,6-TETRA-O-SULFONATO-ALPHA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN GU3 METHYL 3-O-METHYL-2,6-DI-O-SULFO-ALPHA-D-GLUCOSIDE; HETSYN 2 GU3 METHYL 3-O-METHYL-2,6-DI-O-SULFO-D-GLUCOSIDE; METHYL HETSYN 3 GU3 3-O-METHYL-2,6-DI-O-SULFO-GLUCOSIDE HETSYN GU2 2,3-DI-O-METHYL-ALPHA-L-IDURONIC ACID; 2,3-DI-O-METHYL- HETSYN 2 GU2 L-IDURONIC ACID; 2,3-DI-O-METHYL-IDURONIC ACID HETSYN GU6 2,3,6-TRI-O-SULFONATO-ALPHA-D-GLUCOPYRANOSE; 2,3,6-TRI- HETSYN 2 GU6 O-SULFO-ALPHA-D-GLUCOSE; 2,3,6-TRI-O-SULFO-D-GLUCOSE; HETSYN 3 GU6 2,3,6-TRI-O-SULFO-GLUCOSE HETSYN GU1 2,3-DI-O-METHYL-BETA-D-GLUCURONIC ACID; 2,3-DI-O- HETSYN 2 GU1 METHYL-D-GLUCURONIC ACID; 2,3-DI-O-METHYL-GLUCURONIC HETSYN 3 GU1 ACID HETSYN GU5 2,3-DI-O-METHYL-6-O-SULFONATO-ALPHA-D-GLUCOSE; 2,3-DI- HETSYN 2 GU5 O-METHYL-6-O-SULFONATO-D-GLUCOSE; 2,3-DI-O-METHYL-6-O- HETSYN 3 GU5 SULFONATO-GLUCOSE HETSYN GU8 2,3,6-TRI-O-METHYL-BETA-D-GLUCOSE; 2,3,6-TRI-O-METHYL- HETSYN 2 GU8 D-GLUCOSE; 2,3,6-TRI-O-METHYL-GLUCOSE HETSYN GU9 2,3,6-TRI-O-METHYL-ALPHA-D-GLUCOSE; 2,3,6-TRI-O-METHYL- HETSYN 2 GU9 D-GLUCOSE; 2,3,6-TRI-O-METHYL-GLUCOSE HETSYN GU0 2,3,6-TRI-O-SULFONATO-BETA-D-GLUCOSE; 2,3,6-TRI-O- HETSYN 2 GU0 SULFONATO-D-GLUCOSE; 2,3,6-TRI-O-SULFONATO-GLUCOSE HETSYN GU4 2,3,4,6-TETRA-O-SULFONATO-ALPHA-D-GLUCOSE; 2,3,4,6- HETSYN 2 GU4 TETRA-O-SULFONATO-D-GLUCOSE; 2,3,4,6-TETRA-O- HETSYN 3 GU4 SULFONATO-GLUCOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 6 NAG 7(C8 H15 N O6) FORMUL 6 FUC 3(C6 H12 O5) FORMUL 8 GU3 C8 H16 O12 S2 FORMUL 8 GU2 C8 H14 O7 FORMUL 8 GU6 2(C6 H12 O15 S3) FORMUL 8 GU1 C8 H14 O7 FORMUL 8 GU5 2(C8 H15 O9 S 1-) FORMUL 8 GU8 4(C9 H18 O6) FORMUL 8 GU9 3(C9 H18 O6) FORMUL 8 GU0 C6 H9 O15 S3 3- FORMUL 8 GU4 C6 H12 O18 S4 FORMUL 9 BMA C6 H12 O6 FORMUL 9 MAN 3(C6 H12 O6) FORMUL 11 GOL 12(C3 H8 O3) FORMUL 13 SO4 6(O4 S 2-) FORMUL 30 HOH *389(H2 O) HELIX 1 1 ASN A 1K GLY A 1F 1 6 HELIX 2 2 PHE A 7 SER A 11 5 5 HELIX 3 3 THR A 14B SER A 14I 1 8 HELIX 4 4 ALA B 55 CYS B 58 5 4 HELIX 5 5 PRO B 60B ASP B 60E 5 4 HELIX 6 6 THR B 60I ASN B 62 5 3 HELIX 7 7 ASP B 125 LEU B 130 1 9 HELIX 8 8 GLU B 164 SER B 171 1 8 HELIX 9 9 LYS B 185 GLY B 186C 5 5 HELIX 10 10 LEU B 234 GLY B 246 1 13 HELIX 11 11 ASN C 1K GLY C 1F 1 6 HELIX 12 12 PHE C 7 SER C 11 5 5 HELIX 13 13 GLU C 14C SER C 14I 1 7 HELIX 14 14 ALA D 55 LEU D 59 1 5 HELIX 15 15 PRO D 60B ASP D 60E 5 4 HELIX 16 16 THR D 60I ASN D 62 5 3 HELIX 17 17 ASP D 125 LEU D 130 1 9 HELIX 18 18 GLU D 164 SER D 171 1 8 HELIX 19 19 LEU D 234 GLY D 246 1 13 HELIX 20 20 ASN I 45 SER I 69 1 25 HELIX 21 21 SER I 79 LEU I 92 1 14 HELIX 22 22 CYS I 95 PHE I 106 1 12 HELIX 23 23 LYS I 107 ILE I 111 5 5 HELIX 24 24 SER I 112 GLN I 118 1 7 HELIX 25 25 GLN I 118 TYR I 131 1 14 HELIX 26 26 ASN I 155 GLY I 167 1 13 HELIX 27 27 ASN I 178 THR I 194 1 17 HELIX 28 28 SER I 230 THR I 234 5 5 HELIX 29 29 ALA I 264 GLY I 266 5 3 HELIX 30 30 SER I 291 LEU I 299 1 9 HELIX 31 31 THR I 300 LEU I 311 1 12 HELIX 32 32 SER I 330 ASP I 337 1 8 HELIX 33 33 VAL I 341 SER I 345 5 5 SHEET 1 A 7 SER B 20 ASP B 21 0 SHEET 2 A 7 GLN B 156 PRO B 161 -1 O VAL B 157 N SER B 20 SHEET 3 A 7 LYS B 135 GLY B 140 -1 N VAL B 138 O VAL B 158 SHEET 4 A 7 PRO B 198 LYS B 202 -1 O VAL B 200 N ARG B 137 SHEET 5 A 7 TRP B 207 TRP B 215 -1 O TYR B 208 N MET B 201 SHEET 6 A 7 GLY B 226 HIS B 230 -1 O PHE B 227 N TRP B 215 SHEET 7 A 7 MET B 180 ALA B 183 -1 N PHE B 181 O TYR B 228 SHEET 1 B 7 GLN B 30 ARG B 35 0 SHEET 2 B 7 GLU B 39 LEU B 46 -1 O GLU B 39 N ARG B 35 SHEET 3 B 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 4 B 7 ALA B 104 LEU B 108 -1 O MET B 106 N VAL B 52 SHEET 5 B 7 LYS B 81 ILE B 90 -1 N GLU B 86 O LYS B 107 SHEET 6 B 7 LEU B 64 ILE B 68 -1 N ILE B 68 O LYS B 81 SHEET 7 B 7 GLN B 30 ARG B 35 -1 N PHE B 34 O LEU B 65 SHEET 1 C 2 LEU B 60 TYR B 60A 0 SHEET 2 C 2 LYS B 60F ASN B 60G-1 O LYS B 60F N TYR B 60A SHEET 1 D 7 SER D 20 ASP D 21 0 SHEET 2 D 7 GLN D 156 PRO D 161 -1 O VAL D 157 N SER D 20 SHEET 3 D 7 LYS D 135 GLY D 140 -1 N VAL D 138 O VAL D 158 SHEET 4 D 7 PRO D 198 LYS D 202 -1 O VAL D 200 N ARG D 137 SHEET 5 D 7 TRP D 207 TRP D 215 -1 O TYR D 208 N MET D 201 SHEET 6 D 7 GLY D 226 HIS D 230 -1 O PHE D 227 N TRP D 215 SHEET 7 D 7 MET D 180 ALA D 183 -1 N PHE D 181 O TYR D 228 SHEET 1 E 7 LYS D 81 SER D 83 0 SHEET 2 E 7 LEU D 64 ILE D 68 -1 N ILE D 68 O LYS D 81 SHEET 3 E 7 GLN D 30 ARG D 35 -1 N PHE D 34 O LEU D 65 SHEET 4 E 7 GLU D 39 LEU D 46 -1 O ALA D 44 N VAL D 31 SHEET 5 E 7 TRP D 51 THR D 54 -1 O LEU D 53 N SER D 45 SHEET 6 E 7 ALA D 104 LEU D 108 -1 O ALA D 104 N THR D 54 SHEET 7 E 7 LEU D 85 ILE D 90 -1 N TYR D 89 O LEU D 105 SHEET 1 F 2 LEU D 60 TYR D 60A 0 SHEET 2 F 2 LYS D 60F ASN D 60G-1 O LYS D 60F N TYR D 60A SHEET 1 G 7 ILE I 76 LEU I 78 0 SHEET 2 G 7 ILE I 420 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 G 7 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 G 7 ILE I 279 LEU I 285 -1 N VAL I 282 O PHE I 411 SHEET 5 G 7 GLN I 268 PRO I 273 -1 N GLN I 268 O LEU I 285 SHEET 6 G 7 CYS I 247 ARG I 262 -1 N ARG I 261 O VAL I 269 SHEET 7 G 7 ARG I 235 PHE I 239 -1 N PHE I 239 O CYS I 247 SHEET 1 H 8 ILE I 76 LEU I 78 0 SHEET 2 H 8 ILE I 420 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 H 8 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 H 8 ILE I 279 LEU I 285 -1 N VAL I 282 O PHE I 411 SHEET 5 H 8 GLN I 268 PRO I 273 -1 N GLN I 268 O LEU I 285 SHEET 6 H 8 CYS I 247 ARG I 262 -1 N ARG I 261 O VAL I 269 SHEET 7 H 8 GLU I 312 PRO I 321 -1 O MET I 320 N MET I 252 SHEET 8 H 8 PHE I 402 LYS I 403 1 O PHE I 402 N HIS I 319 SHEET 1 I 5 GLN I 171 LEU I 173 0 SHEET 2 I 5 SER I 138 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 I 5 LEU I 213 LEU I 224 -1 O LYS I 222 N LYS I 139 SHEET 4 I 5 ASP I 366 VAL I 375 1 O ASP I 366 N LEU I 215 SHEET 5 I 5 PHE I 323 GLU I 326 -1 N PHE I 323 O VAL I 375 SHEET 1 J 4 GLN I 171 LEU I 173 0 SHEET 2 J 4 SER I 138 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 J 4 LEU I 213 LEU I 224 -1 O LYS I 222 N LYS I 139 SHEET 4 J 4 GLY I 379 SER I 380 -1 O SER I 380 N GLY I 223 SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.04 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.04 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.04 SSBOND 5 CYS C 1 CYS D 122 1555 1555 2.04 SSBOND 6 CYS D 42 CYS D 58 1555 1555 2.04 SSBOND 7 CYS D 168 CYS D 182 1555 1555 2.04 SSBOND 8 CYS D 191 CYS D 220 1555 1555 2.04 SSBOND 9 CYS I 8 CYS I 128 1555 1555 2.04 SSBOND 10 CYS I 21 CYS I 95 1555 1555 2.04 SSBOND 11 CYS I 247 CYS I 430 1555 1555 2.03 SSBOND 12 CYS I 317 CYS I 401 1555 1555 2.03 LINK ND2 ASN B 60G C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN D 60G C1 NAG F 1 1555 1555 1.46 LINK ND2 ASN I 96 C1 NAG H 1 1555 1555 1.46 LINK ND2 ASN I 155 C1 NAG I 801 1555 1555 1.45 LINK ND2 ASN I 192 C1 NAG J 1 1555 1555 1.45 LINK O6 NAG E 1 C1 FUC E 2 1555 1555 1.41 LINK O6 NAG F 1 C1 FUC F 2 1555 1555 1.41 LINK O4 GU3 G 1 C1 GU2 G 2 1555 1555 1.44 LINK O4 GU2 G 2 C1 GU6 G 3 1555 1555 1.44 LINK O4 GU6 G 3 C1 GU1 G 4 1555 1555 1.44 LINK O4 GU1 G 4 C1 GU5 G 5 1555 1555 1.44 LINK O4 GU5 G 5 C1 GU8 G 6 1555 1555 1.43 LINK O4 GU8 G 6 C1 GU9 G 7 1555 1555 1.44 LINK O4 GU9 G 7 C1 GU8 G 8 1555 1555 1.44 LINK O4 GU8 G 8 C1 GU9 G 9 1555 1555 1.44 LINK O4 GU9 G 9 C1 GU8 G 10 1555 1555 1.44 LINK O4 GU8 G 10 C1 GU9 G 11 1555 1555 1.44 LINK O4 GU9 G 11 C1 GU8 G 12 1555 1555 1.43 LINK O4 GU8 G 12 C1 GU5 G 13 1555 1555 1.44 LINK O4 GU5 G 13 C1 GU0 G 14 1555 1555 1.44 LINK O4 GU0 G 14 C1 GU6 G 15 1555 1555 1.44 LINK O4 GU6 G 15 C1 GU4 G 16 1555 1555 1.44 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.39 LINK O6 NAG H 1 C1 FUC H 7 1555 1555 1.41 LINK O4 NAG H 2 C1 BMA H 3 1555 1555 1.39 LINK O3 BMA H 3 C1 MAN H 4 1555 1555 1.41 LINK O6 BMA H 3 C1 MAN H 6 1555 1555 1.40 LINK O2 MAN H 4 C1 MAN H 5 1555 1555 1.40 LINK O4 NAG J 1 C1 NAG J 2 1555 1555 1.39 CISPEP 1 SER B 36A PRO B 37 0 -0.26 CISPEP 2 SER D 36A PRO D 37 0 -0.32 CISPEP 3 VAL I 415 PRO I 416 0 0.62 CRYST1 59.280 59.530 108.410 77.55 78.94 68.08 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016869 -0.006788 -0.002252 0.00000 SCALE2 0.000000 0.018107 -0.002900 0.00000 SCALE3 0.000000 0.000000 0.009519 0.00000